Javascript must be enabled to continue!
Molecular Dynamics Simulations Support Multiple Binding Sites for Phospholamban on SERCA
View through CrossRef
Ion‐motive ATPases use the energy of ATP hydrolysis to transport ions across membrane bilayer against a concentration gradient. Here we investigate the functional regulation of the sarco(endo)plasmic reticulum calcium ATPase (SERCA), which plays a key role in cellular Ca handling. In the heart, the activity of the SERCA is regulated by its inhibitory partner phospholamban (PLB). PLB has been shown to inhibit the transporter by binding to the SERCA M6 helix, but this site is not available when SERCA is bound to Ca. Our previous fluorescence resonance energy transfer (FRET) experiments suggested that SERCA Ca binding causes PLB to translocate from the known binding site to a putative secondary site. Based on an analogous interaction of the sodium/potassium ATPase (NKA) with a regulatory partner (FXYD10), we hypothesized that PLB could interact with the M9 helix on SERCA after leaving the canonical binding site. In the present study we performed molecular dynamics simulations to compare the energetics of binding of PLB to candidate sites on SERCA. We created models of the regulatory complex using structural information from available crystal structures of the PLB‐SERCA and FXYD10‐NKA complexes. Quantification of the interaction energies of these models suggested PLB can form a stable complex with both the canonical (−856 kJ/mol) and the proposed secondary site (−510 kJ/mol). In contrast, docking of PLB to the M3 helix on the opposite side of SERCA shows a much less favorable interaction energy (−108 kJ/mol). We also used umbrella sampling to quantify the free energy of PLB bound to several candidate binding sites on SERCA transmembrane domain. The results provide insight into the relative affinity of PLB for plausible sites of interaction on SERCA. Overall, the molecular dynamics simulations support a 2‐site model in which PLB interacts first with the high affinity conventional site and then relocates to a nearby secondary site when SERCA binds calcium.
Title: Molecular Dynamics Simulations Support Multiple Binding Sites for Phospholamban on SERCA
Description:
Ion‐motive ATPases use the energy of ATP hydrolysis to transport ions across membrane bilayer against a concentration gradient.
Here we investigate the functional regulation of the sarco(endo)plasmic reticulum calcium ATPase (SERCA), which plays a key role in cellular Ca handling.
In the heart, the activity of the SERCA is regulated by its inhibitory partner phospholamban (PLB).
PLB has been shown to inhibit the transporter by binding to the SERCA M6 helix, but this site is not available when SERCA is bound to Ca.
Our previous fluorescence resonance energy transfer (FRET) experiments suggested that SERCA Ca binding causes PLB to translocate from the known binding site to a putative secondary site.
Based on an analogous interaction of the sodium/potassium ATPase (NKA) with a regulatory partner (FXYD10), we hypothesized that PLB could interact with the M9 helix on SERCA after leaving the canonical binding site.
In the present study we performed molecular dynamics simulations to compare the energetics of binding of PLB to candidate sites on SERCA.
We created models of the regulatory complex using structural information from available crystal structures of the PLB‐SERCA and FXYD10‐NKA complexes.
Quantification of the interaction energies of these models suggested PLB can form a stable complex with both the canonical (−856 kJ/mol) and the proposed secondary site (−510 kJ/mol).
In contrast, docking of PLB to the M3 helix on the opposite side of SERCA shows a much less favorable interaction energy (−108 kJ/mol).
We also used umbrella sampling to quantify the free energy of PLB bound to several candidate binding sites on SERCA transmembrane domain.
The results provide insight into the relative affinity of PLB for plausible sites of interaction on SERCA.
Overall, the molecular dynamics simulations support a 2‐site model in which PLB interacts first with the high affinity conventional site and then relocates to a nearby secondary site when SERCA binds calcium.
Related Results
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
Abstract
Background
Epetraborole (EBO) is an orally available, bacterial leucyl transfer RNA synthetase inhibitor that concentra...
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
Abstract
Background
SUL-DUR is a β-lactam/β-lactamase inhibitor combination in development for the treatment of ABC infections, ...
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
Abstract
Background
Epetraborole (EBO), an orally available bacterial leucyl transfer RNA synthetase inhibitor with potent activ...
592. Impact of Elevated MIC Values on Echinocandin Pharmacokinetic-Pharmacodynamic (PK-PD) Candida glabrata Target Attainment (TA)
592. Impact of Elevated MIC Values on Echinocandin Pharmacokinetic-Pharmacodynamic (PK-PD) Candida glabrata Target Attainment (TA)
Abstract
Background
Given the increasing prevalence of non-albicans Candida species, including C. glabrata and C. auris, which h...
SERCA isoform expression in paralyzed muscle
SERCA isoform expression in paralyzed muscle
The influence of paralysis on the expression of sarco(endo)plasmic reticulum calcium ATPase (SERCA) pump isoforms in the rat soleus muscle was assessed. Paralysis was induced in ra...
Cation binding to SERCA
Cation binding to SERCA
Sarcoendoplasmic reticulum Ca2+-ATPase (SERCA) is a transmembrane pump that plays an important role in transporting calcium into the sarcoplasmic reticulum (SR). While Ca2+ binds S...
Protein Docking and Steered Molecular Dynamics Reveal Alternative Regulatory Sites on the SERCA Calcium Transporter
Protein Docking and Steered Molecular Dynamics Reveal Alternative Regulatory Sites on the SERCA Calcium Transporter
AbstractThe transport activity of the calcium ATPase SERCA is modulated by an inhibitory interaction with a 52-residue transmembrane peptide, phospholamban (PLB). Biochemical and s...
Sarcoplasmic reticulum Ca2+-ATPase (SERCA) activity during the transition to endothermy in an altricial bird
Sarcoplasmic reticulum Ca2+-ATPase (SERCA) activity during the transition to endothermy in an altricial bird
ABSTRACTSarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) is a transmembrane pump critical to muscle calcium cycling during contraction, and SERCA has also been proposed as the basi...

